{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:33:51Z","timestamp":1790645631432,"version":"4.1.0"},"reference-count":24,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Shigellosis is a reportable infectious disease. It can present as a severe bloody diarrhoea but is often asymptomatic.<jats:italic>Shigella<\/jats:italic>can be sexually transmissible. We performed a study among symptomatic and asymptomatic men who have sex with men (MSM) to assess the prevalence of<jats:italic>Shigella, Salmonella<\/jats:italic>and<jats:italic>Campylobacter<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From March to June 2020, MSM attending the Amsterdam centre for sexual health were consecutively included. Predefined minimal numbers of inclusion of 150, 100 and 50 were determined, respectively, for MSM who reported no diarrhoea, diarrhoea during last month or diarrhoea on the day of visit to clinic. Anal samples were tested for the presence of<jats:italic>Shigella<\/jats:italic>,<jats:italic>Salmonella<\/jats:italic>and<jats:italic>Campylobacter<\/jats:italic>. During the same period, the frequency of these bacteria was assessed in routinely tested samples requested by general physicians or nursing home physicians. Characteristics of included MSM were compared between the men with different diarrhoea anamnesis, and the prevalence of shigellosis was estimated in each group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 212 MSM without diarrhoea, 109 MSM who recently had diarrhoea and 68 MSM who reported diarrhoea on the day of clinic visit. Thirteen (3.3%, 95%\u2009CI 1.7% to 5.6%) MSM were infected with<jats:italic>Shigella<\/jats:italic>, none with<jats:italic>Salmonella<\/jats:italic>and 7 (1.8%, 95%\u2009CI 0.7% to 3.7%) with<jats:italic>Campylobacter. Shigella<\/jats:italic>prevalence was 2.8% (95% CI 1.0% to 6.1%) in asymptomatic men, 3.7% (95% CI 1.0% to 9.1%) in men who recently had diarrhoea and 4.4% (95% CI 0.9% to 12.4%) in men with current diarrhoea (p=0.799).<jats:italic>Shigella<\/jats:italic>was more frequently found in MSM who had used pre-exposure prophylaxis (PrEP) in the preceding 3\u2009months (10\/151), compared with those not having used PrEP (2\/146) or being HIV positive (1\/75) (p=0.038).<jats:italic>Shigella<\/jats:italic>was significantly more often detected among MSM compared with routinely obtained faecal samples being 11\/770 (1.4%) (p=0.031).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:italic>Shigella<\/jats:italic>infections are relatively common in both symptomatic and asymptomatic MSM. Future studies should focus on the risk of onward transmission via asymptomatic persons.<\/jats:p><jats:p><jats:bold>Samenvatting<\/jats:bold><\/jats:p><jats:p><jats:bold>Introductie<\/jats:bold><\/jats:p><jats:p>Shigellose is een meldingsplichtige infectieziekte. Het kan zich presenteren als een ernstige bloederige diarree, maar is vaak asymptomatisch.<jats:italic>Shigella<\/jats:italic>kan seksueel overdraagbaar zijn. We hebben een onderzoek uitgevoerd onder symptomatische en asymptomatische mannen die seks hebben met mannen (MSM) om de prevalentie van<jats:italic>Shigella, Salmonella<\/jats:italic>en<jats:italic>Campylobacter<\/jats:italic>te bepalen.<\/jats:p><jats:p><jats:bold>Methoden<\/jats:bold><\/jats:p><jats:p>Van maart tot juni 2020 werden achtereenvolgens MSM van het Amsterdamse centrum voor seksuele gezondheid opgenomen. Vooraf gedefinieerde minimale aantallen van inclusie van respectievelijk 150, 100 en 50 waren bepaald voor MSM die geen diarree, diarree in de afgelopen maand of diarree op de dag van bezoek aan de kliniek meldden. Anale monsters werden getest op de aanwezigheid van<jats:italic>Shigella, Salmonella<\/jats:italic>en<jats:italic>Campylobacter<\/jats:italic>. In dezelfde periode werd de frequentie van deze bacteri\u00ebn bepaald in routinematig geteste monsters aangevraagd door huisartsen of verpleeghuisartsen. Kenmerken van ge\u00efncludeerde MSM werden vergeleken tussen mannen met verschillende diarree anamnese, en de prevalentie van shigellose werd in elke groep geschat.<\/jats:p><jats:p><jats:bold>Resultaten<\/jats:bold><\/jats:p><jats:p>We includeerden 212 MSM zonder diarree, 109 MSM die onlangs diarree hadden en 68 MSM die diarree meldden op de dag van het bezoek aan de kliniek. Dertien (3,3%, 95% CI 1,7-5,6%) MSM waren ge\u00efnfecteerd met<jats:italic>Shigella<\/jats:italic>, geen enkele met<jats:italic>Salmonella<\/jats:italic>, en 7 (1,8%, 95% CI 0,7-3,7%) met<jats:italic>Campylobacter<\/jats:italic>. De prevalentie van<jats:italic>Shigella<\/jats:italic>was 2,8% (95%CI 1,0-6,1%) bij asymptomatische mannen, 3,7% (95%CI 1,0-9,1%) bij mannen die recent diarree hadden en 4,4% (95%CI 0,9-12,4%) bij mannen met huidige diarree (P=0,799).<jats:italic>Shigella<\/jats:italic>werd vaker gevonden bij MSM die in de voorgaande drie maanden (10\/151) PrEP hadden gebruikt dan bij mensen die geen PrEP hadden gebruikt (2\/146) of hiv-positief waren (1\/75) (p=0,038).<jats:italic>Shigella<\/jats:italic>werd significant vaker gedetecteerd bij MSM in vergelijking met routinematig verkregen fecale monsters, namelijk 11\/770 (1,4%) (p=0,031).<\/jats:p><jats:p><jats:bold>Conclusie<\/jats:bold><\/jats:p><jats:p><jats:italic>Shigella<\/jats:italic>infecties komen relatief vaak voor bij zowel symptomatische als asymptomatische MSM. Toekomstige studies moeten zich richten op het risico van verdere overdracht via asymptomatische personen.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2021-055274","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T18:20:34Z","timestamp":1644603634000},"page":"564-569","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["<i>Shigella<\/i>is common in symptomatic and asymptomatic men who have sex with men visiting a sexual health clinic in Amsterdam"],"prefix":"10.1136","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5043-3424","authenticated-orcid":false,"given":"Joyce F.","family":"Braam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4897-4261","authenticated-orcid":false,"given":"Sylvia M.","family":"Bruisten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariska","family":"Hoogeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9784-547X","authenticated-orcid":false,"given":"Henry J.C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-7002","authenticated-orcid":false,"given":"Maarten F.","family":"Schim van der Loeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alje P.","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"2023100200001840000_98.8.564.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33296-8"},{"key":"2023100200001840000_98.8.564.2","unstructured":"De Gier B , Nijsten DRE , Duijster JW , et al . State of infectious diseases in the Netherlands, 2016. Centre for Infectious Disease control, Epidemiology and Surveillance, RIVM, Bilthoven, 2017."},{"key":"2023100200001840000_98.8.564.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30276-1"},{"key":"2023100200001840000_98.8.564.4","unstructured":"National Institute for Health and Environment (RIVM) . LCI Guideline Shigellosis 2017 [In Dutch], 2019. Available: https:\/\/lci.rivm.nl\/richtlijnen\/shigellose"},{"key":"2023100200001840000_98.8.564.5","unstructured":"Centers for Disease Control and Prevention . Shigellosis (Shigella spp.) 2017 case definition, 2017. Available: https:\/\/wwwn.cdc.gov\/nndss\/conditions\/shigellosis\/case-definition\/2017\/"},{"key":"2023100200001840000_98.8.564.6","unstructured":"Communicable Diseases Network Australia . Shigellosis surveillance case definition, 2018. Available: https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-surveil-nndss-casedefs-cd_shigel.htm"},{"key":"2023100200001840000_98.8.564.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.03.017"},{"key":"2023100200001840000_98.8.564.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2017.09.025"},{"key":"2023100200001840000_98.8.564.9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4659-y"},{"key":"2023100200001840000_98.8.564.10","doi-asserted-by":"publisher","DOI":"10.3201\/eid2704.202337"},{"key":"2023100200001840000_98.8.564.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz783"},{"key":"2023100200001840000_98.8.564.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00002-X"},{"key":"2023100200001840000_98.8.564.13","doi-asserted-by":"publisher","DOI":"10.3201\/eid2302.161203"},{"key":"2023100200001840000_98.8.564.14","doi-asserted-by":"publisher","DOI":"10.3201\/eid2211.160653"},{"key":"2023100200001840000_98.8.564.15","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2015-052014"},{"key":"2023100200001840000_98.8.564.16","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268812002166"},{"key":"2023100200001840000_98.8.564.17","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.18-0962"},{"key":"2023100200001840000_98.8.564.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197305312882207"},{"key":"2023100200001840000_98.8.564.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.02.007"},{"key":"2023100200001840000_98.8.564.20","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2016-053057"},{"key":"2023100200001840000_98.8.564.21","doi-asserted-by":"publisher","DOI":"10.3201\/eid1905.121344"},{"key":"2023100200001840000_98.8.564.22","doi-asserted-by":"publisher","DOI":"10.1086\/375590"},{"key":"2023100200001840000_98.8.564.23","article-title":"The role of saliva in gonorrhoea and chlamydia transmission to extragenital sites among men who have sex with men: new insights into transmission","volume":"22 Suppl 6","author":"Chow","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2023100200001840000_98.8.564.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106276"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2021-055274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:00:51Z","timestamp":1696230051000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2021-055274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,11,17]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/sextrans-2021-055274"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2021-055274","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]}}}